Artificial Intelligence ‘Outsmarts Cancer’
June 8, 2016
(BBC) – Early trial data shows a drug developed using artificial intelligence can slow the growth of cancer in clinical trials. The data, presented at the American Society of Clinical Oncology conference, showed some tumours shrank by around a quarter. The compound will now be taken into more advanced trials.Scientists said we were now in an explosive stage of merging advances in computing with medicine.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.